Integration of Sage Intacct, Grant of Restricted Share Units, & Update on Private Placement
Integration of Sage Intacct, Grant of Restricted Share Units, & Update on Private Placement
Toronto, Ontario--(Newsfile Corp. - January 10, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce the seamless integration of Sage Intacct across its subsidiaries.
安大略省多倫多--（Newsfile Corp.，2024年1月10日）——加拿大B2B遠程醫療解決方案領導者LevelJump Healthcare Corp.（TSXV：JUMP）（OTCQB：JMPHF）（FSE：75J）（“LevelJump” 或 “公司”）很高興地宣佈Sage Intacct在其子公司之間無縫整合。
This advanced solution optimizes the accounting and HR processes and should result in cost savings and efficiencies for JUMP as the Company acquires more locations and continues to grow operations. The integration of Sage is planned to go live this quarter.
這種先進的解決方案優化了會計和人力資源流程，隨着公司收購更多地點和業務的持續增長，應爲JUMP節省成本和提高效率。Sage的整合計劃於本季度上線。
"LevelJump remains committed to innovation and continuous improvement, and the integration of Sage Intacct reflects our dedication to providing operational excellence. We look forward to the positive impact this collaboration will have on our financial capabilities and overall business success." Said Rob Landau, CFO.
“LevelJump仍然致力於創新和持續改進，Sage Intacct的整合反映了我們致力於提供卓越運營的決心。我們期待這種合作對我們的財務能力和整體業務成功產生積極影響。”首席財務官羅布·蘭道說。
Grant of Restricted Share Units ("RSUs")
授出限制性股票單位（“RSU”）
The Company is also pleased to announce that it has issued 60,000 common shares pursuant to the redemption of 60,000 Restricted Share Units ("RSUs") originally granted to an employee on January 1, 2021.
公司還高興地宣佈，根據最初於2021年1月1日授予員工的6萬個限制性股票單位（“RSU”）的贖回，它已發行了6萬股普通股。
The deemed issue price of these shares is 40,000 at $0.12 per share and 20,000 at $0.11 per share. The issue price was determined based on the date the RSUs vested.
這些股票的認定發行價格爲40,000美元，每股0.12美元，20,000股，每股0.11美元。發行價格是根據限制性股票單位的歸屬日期確定的。
Update on Non-Brokered Private Placement
非經紀私募股權最新情況
The Company also wishes to announce that, following receipt of Exchange approval, and further to its news releases dated September 14, 2023, and October 28, 2023, there have been no further closings under the Company's previous private placement.
該公司還希望宣佈，在獲得交易所批准後，繼其於2023年9月14日和2023年10月28日發佈的新聞稿之後，公司先前的私募沒有進一步成交。
Information on a new preferred share offering can be found in the Company's press release dated November 28, 2023.
有關新優先股發行的信息可以在公司2023年11月28日的新聞稿中找到。
About LevelJump Healthcare
關於 LevelJump
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
LevelJump Healthcare Corp.（多倫多證券交易所股票代碼：JUMP）通過其遠程放射學部門爲客戶醫院和成像中心提供遠程醫療解決方案，並通過其IHF（獨立醫療機構）提供面對面放射學服務。JUMP主要專注於緊急和急診患者的重症監護，在我們所服務的社區中建立不可或缺的關係。
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
代表董事會
LEVELJUMP 醫療保健公司
Mitchell Geisler
Chief Executive Officer
米切爾·蓋斯勒
首席執行官
Caitlin-Robyn Densmore
Investor Relations Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
Caitlin-Robyn Densmore
投資者關係經理
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
關於前瞻性信息的警示性聲明
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
本新聞稿包含適用證券法所指與公司業務計劃和公司行業前景有關的 “前瞻性信息”。儘管公司認爲，根據其高管和董事的經驗、當前狀況和預期的未來發展以及其他被認爲合適的因素，這些前瞻性信息中反映的預期是合理的，但不應過度依賴這些預期，因爲公司無法保證這些預期會被證明是正確的。實際結果和發展可能與這些聲明所設想的結果和事態發展存在重大差異。本新聞稿中的聲明自本新聞稿發佈之日起作出，除適用證券法要求外，公司不承擔更新或修改聲明以反映新事件或情況的責任。公司沒有義務評論第三方對公司、加拿大電信服務公司、其證券或各自財務或經營業績（如適用）的分析、預期或陳述。
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
交易所及其監管服務提供商（該術語在交易所政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
所發行的證券過去和將來都沒有根據經修訂的1933年《美國證券法》（“美國證券法”）或任何美國州證券法進行註冊，也不得在美國發行或出售，也不得向未經註冊或適用《美國證券法》和適用的美國州證券法註冊要求豁免的美國人發行或出售，也不得爲美國人的賬戶或利益進行發行或出售。本新聞稿不構成在美國或任何其他司法管轄區出售證券的要約或要求購買證券的要約。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。